Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 309
7
Diseases
2
Unique genes
0.437
Avg. similarity score
Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies
Most-connected disease (6 links)
Disease
Searched: Hfe hemochromatosis, modifier of
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Hfe hemochromatosis, modifier of
Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies
20p12.3 microdeletion syndrome
Right ventricle hypoplasia
Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 1
Short stature, palatal anomalies, congenital heart disease, and skeletal malformations
Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 2
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies | 6 | 6 | 2 |
| 20p12.3 microdeletion syndrome | 5 | 5 | 1 |
| Hfe hemochromatosis, modifier of | 5 | 5 | 1 |
| Right ventricle hypoplasia | 5 | 5 | 1 |
| Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 1 | 5 | 5 | 1 |
| Short stature, palatal anomalies, congenital heart disease, and skeletal malformations | 5 | 5 | 1 |
| Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 2 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| BMP2 | 6 / 7 | 20p12.3 microdeletion syndrome, Hfe hemochromatosis, modifier of, Right ventricle hypoplasia, Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies and 2 more |
| SCUBE3 | 2 / 7 | Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies, Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 2 |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Transcriptional regulation by RUNX2 | Reactome | 1 / 12 | 500× | 2.00e-3 | 1.90e-2 ✓ sig. |
| Signaling by BMP | Reactome | 1 / 28 | 214× | 4.66e-3 | 3.48e-2 ✓ sig. |
| Molecules associated with elastic fibres | Reactome | 1 / 38 | 158× | 6.32e-3 | 4.25e-2 ✓ sig. |
| Basal cell carcinoma | KEGG | 1 / 63 | 95.3× | 1.05e-2 | 5.84e-2 |
| Degradation of the extracellular matrix | Reactome | 1 / 70 | 85.8× | 1.16e-2 | 6.22e-2 |
| TGF-beta signaling pathway | KEGG | 1 / 108 | 55.6× | 1.79e-2 | 8.04e-2 |
| Hippo signaling pathway | KEGG | 1 / 157 | 38.2× | 2.60e-2 | 9.97e-2 |
| Cytokine-cytokine receptor interaction | KEGG | 1 / 298 | 20.2× | 4.90e-2 | 1.43e-1 |
| Pathways in cancer | KEGG | 1 / 533 | 11.3× | 8.68e-2 | 1.99e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| positive regulation of osteoblast differentiation | GO:0045669 | 2 / 78 | 240× | 1.72e-5 | 8.24e-4 ✓ sig. |
| negative regulation of calcium-independent cell-cell adhesion | GO:0051042 | 1 / 1 | 9,344× | 1.07e-4 | 3.25e-3 ✓ sig. |
| endodermal-mesodermal cell signaling | GO:0003133 | 1 / 2 | 4,672× | 2.14e-4 | 5.31e-3 ✓ sig. |
| cardiac atrium formation | GO:0003210 | 1 / 2 | 4,672× | 2.14e-4 | 5.31e-3 ✓ sig. |
| cardiocyte differentiation | GO:0035051 | 1 / 2 | 4,672× | 2.14e-4 | 5.31e-3 ✓ sig. |
| mesenchymal cell proliferation involved in ureteric bud development | GO:0072138 | 1 / 2 | 4,672× | 2.14e-4 | 5.31e-3 ✓ sig. |
| regulation of cardiac muscle cell differentiation | GO:2000725 | 1 / 2 | 4,672× | 2.14e-4 | 5.31e-3 ✓ sig. |
| positive regulation of extracellular matrix constituent secretion | GO:0003331 | 1 / 3 | 3,115× | 3.21e-4 | 7.04e-3 ✓ sig. |
| positive regulation of phosphatase activity | GO:0010922 | 1 / 3 | 3,115× | 3.21e-4 | 7.04e-3 ✓ sig. |
| embryonic heart tube anterior/posterior pattern specification | GO:0035054 | 1 / 3 | 3,115× | 3.21e-4 | 7.04e-3 ✓ sig. |
| corticotropin hormone secreting cell differentiation | GO:0060128 | 1 / 3 | 3,115× | 3.21e-4 | 7.04e-3 ✓ sig. |
| positive regulation of bone mineralization involved in bone maturation | GO:1900159 | 1 / 3 | 3,115× | 3.21e-4 | 7.04e-3 ✓ sig. |
| negative regulation of aldosterone biosynthetic process | GO:0032348 | 1 / 4 | 2,336× | 4.28e-4 | 8.53e-3 ✓ sig. |
| cardiac jelly development | GO:1905072 | 1 / 4 | 2,336× | 4.28e-4 | 8.53e-3 ✓ sig. |
| atrioventricular canal morphogenesis | GO:1905222 | 1 / 4 | 2,336× | 4.28e-4 | 8.53e-3 ✓ sig. |